MedRepair
米蓓尔
MedRepair, a functional skincare brand developed specifically for sensitive skin, was officially launched in 2018. Its product range includes the Little Blue Cap essence, powder water, freeze-dried facial mask, and other series.
MedRepair, a professional functional skincare brand under Bloomage Biotech, is tailored for sensitive skin. Since its inception, MedRepair has continuously collaborated with numerous renowned dermatologists, participating in Chinese and international dermatological research forums, aiding consumers in correctly understanding their skin. Based on the product philosophy of “graded repair and skin-specific customization,” and integrating Bloomage Biotech’s cutting-edge technology, MedRepair helps improve skin sensitivity and fosters the creation of healthy, vibrant skin.
Bloomage Biotech (688363) is a well-known biotechnology and bioactive materials company, focusing mainly on functional sugars and amino acids that contribute to human health, committed to bringing new experiences of health, beauty, and happiness to humanity.
The company is a hyaluronic acid full-industry chain platform integrating R&D, production, and sales, holding a leading position in microbial fermentation technology for hyaluronic acid production. Leveraging microbial fermentation and cross-linking technologies, Bloomage Biotech has established a complete industry chain business system from raw materials to medical end products, functional skincare products, and functional foods, serving global manufacturers, medical institutions, and end-users in pharmaceuticals, cosmetics, and food industries.
Bloomage Biotech firmly believes that a company’s vitality comes from continuous innovation and profitability. By establishing a core position in the industry chain, supply chain, and value chain, it ensures the achievement of strategic goals. Through microbial fermentation and cross-linking core technologies, the company aims to become an industry standard setter and leader, relying on its technological and product strength. By leveraging market and brand strength, it becomes a key link in controlling the supply chain’s intermediate segments. With its technological, product, and brand strength, Bloomage Biotech builds competitive advantages, becoming the central hub for optimal resource allocation in the value chain.
Technology and innovation are the guarantees for Bloomage Biotech’s healthy development and new drivers for rapid growth. For 20 years, the company has focused on building brand strength through technology, actively enhancing its scientific and technological innovation. On November 6, 2019, Bloomage Biotech successfully listed on the STAR Market, embarking on a new chapter of innovative development.
In the future, Bloomage Biotech will continue to build its competitive edge centered on technology, product, and brand strength. Utilizing core biotechnologies, it will develop more high-quality bioactive substances and related end products, enhancing their effects on human life and health. By creating products that instill confidence and pride in Chinese people and becoming a nationally respected and beloved enterprise, Bloomage Biotech aims to make a significant impact on a global scale.